MEREO BIOPHARMA (MREO)
(Delayed Data from NSDQ)
$2.95 USD
+0.02 (0.68%)
Updated May 24, 2024 04:00 PM ET
After-Market: $2.96 +0.01 (0.34%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
MEREO BIOPHARMA [MREO]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Accelerated approval path for NAVI
Provider: TRINITY DELTA
Company: MEREO BIOPHARMA
Industry: Unclassified
Encouraging interim BPS-804 data in OI
Provider: TRINITY DELTA
|